MYO5B and heart failure: With further ageing, all MYO5b-KO mice of both sexes developed heart failure by the age of 6 months and displayed a 100% mortality (earliest at 27 weeks of age, latest at 41 weeks of age) (Table 2; Figure 5A; see Supplementary data online, Figures S4A and B and S5B).